Ignite Creation Date:
2024-05-05 @ 5:29 PM
Last Modification Date:
2024-10-26 @ 9:32 AM
Study NCT ID:
NCT00465699
Status:
UNKNOWN
Last Update Posted:
2007-04-25
First Post:
2007-04-23
Brief Title:
Evaluation of Topical B12 for the Treatment of Childhood Atopic Dermatitis
Sponsor:
Spartanburg Regional Family Medicine
Organization:
Spartanburg Regional Family Medicine
Study Overview
Official Title:
Evaluation of Topical B12 for the Treatment of Childhood Atopic Dermatitis
Status:
UNKNOWN
Status Verified Date:
2007-04
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study is being done to see in B12 applied to the skin will improve the symptoms of eczema in children compared to a placebo creme
Detailed Description:
INTRODUCTION Atopic dermatitis is a prevalent disease process in children affecting up to 20 of children in the United States Various treatment options are available to treat atopic dermatitis to include topical emollients topical steroids and topical calcineurin inhibitors Each treatment option has benefits and potential risks This study was done to determine if topical B12 could be a tolerable and efficacious alternative treatment option in this population
METHODS The study was conducted as a placebo-controlled double-blind prospective randomized clinical trial with intraindividual left right comparison Parents were given 2 containers of creams and instructed to apply the Vitamin B12 cream to one side of the body and the placebo cream to the contralateral side according to the randomization scheme
METHODS The study was conducted as a placebo-controlled double-blind prospective randomized clinical trial with intraindividual left right comparison Parents were given 2 containers of creams and instructed to apply the Vitamin B12 cream to one side of the body and the placebo cream to the contralateral side according to the randomization scheme
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None